Description: colorless, clear liquid, with menthol odor.
Composition 100 ml. Active substances: 2.5g menthol racemic, 1.0g procaine hydrochloride (novocaine), 1.0g benzocaine (anesthesin). Excipient: 70% ethyl alcohol till 100ml.
Pharmacology. Menovazine is Combination Product for topical use which contain Menthol Racemic, Benzocaine and Procaine Hydrochloride and has Local Anesthetic action.
Uses and Administration. Menovazine Topical Solution is available for neuralgia, myalgia, arthralgia, pruritic dermatoses. Menovazine is for external use: the duration of treatment depends on the therapeutic results, however, should not exceed 3-4 weeks.
Contraindications: sensitive to its components, skin coating integrity, pregnancy, breast-feeding age, children's age.
Side effects. Allergic reactions are possible. Prolonged use may cause dizziness, general weakness, drop in blood pressure. In these cases, treatment was stopped.
Storage: Stored at temperature not exceeding 25°?, protected from light and away from children.
Shelf life: 2 years.